Characterization of a CC49-based single-chain fragment-beta-lactamase fusion protein for antibody-directed enzyme prodrug therapy (ADEPT).
Alderson RF, Toki BE, Roberge M, Geng W, Basler J, Chin R, Liu A, Ueda R, Hodges D, Escandon E, Chen T, Kanavarioti T, Babé L, Senter PD, Fox JA, Schellenberger V.
Alderson RF, et al. Among authors: chin r.
Bioconjug Chem. 2006 Mar-Apr;17(2):410-8. doi: 10.1021/bc0503521.
Bioconjug Chem. 2006.
PMID: 16536473